113 related articles for article (PubMed ID: 26646832)
1. Delayed Boston Keratoprosthesis Exchange due to a Preceding Vitreoretinal Surgery with Intraoperative Choroidal Detachment.
Relimpio López MI; Gessa Sorroche M; Garrido Hermosilla AM; Laborda Guirao T; Espejo Arjona F; Rodríguez de la Rúa Franch E
Ophthalmologica; 2016; 235(1):61. PubMed ID: 26646832
[TBL] [Abstract][Full Text] [Related]
2. VITREORETINAL COMPLICATIONS IN EYES WITH BOSTON KERATOPROSTHESIS TYPE I.
Rishi P; Rishi E; Koundanya VV; Mathur G; Iyer G; Srinivasan B
Retina; 2016 Mar; 36(3):603-10. PubMed ID: 26398693
[TBL] [Abstract][Full Text] [Related]
3. Vitreoretinal complications of the Boston Keratoprosthesis.
Modjtahedi BS; Eliott D
Semin Ophthalmol; 2014; 29(5-6):338-48. PubMed ID: 25325859
[TBL] [Abstract][Full Text] [Related]
4. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
5. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
6. Keratoprosthesis surgery for end-stage corneal blindness in asian eyes.
Tan DT; Tay AB; Theng JT; Lye KW; Parthasarathy A; Por YM; Chan LL; Liu C
Ophthalmology; 2008 Mar; 115(3):503-510.e3. PubMed ID: 18319104
[TBL] [Abstract][Full Text] [Related]
7. International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.
Alexander JK; Basak SK; Padilla MD; Yu F; Aldave AJ
Cornea; 2015 Nov; 34(11):1387-94. PubMed ID: 26382898
[TBL] [Abstract][Full Text] [Related]
8. Vitreoretinal aspects of permanent keratoprosthesis.
Klufas MA; Yannuzzi NA; D'Amico DJ; Kiss S
Surv Ophthalmol; 2015; 60(3):216-28. PubMed ID: 25890625
[TBL] [Abstract][Full Text] [Related]
9. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
[TBL] [Abstract][Full Text] [Related]
10. ULTRA-WIDEFIELD IMAGING OF POSTERIOR SEGMENT PATHOLOGY IN THE SETTING OF THE BOSTON KERATOPROSTHESIS.
Kornberg DL; Yannuzzi NA; Klufas MA; DʼAmico DJ; Orlin A; Kiss S
Retina; 2016 Jun; 36(6):1101-10. PubMed ID: 26536101
[TBL] [Abstract][Full Text] [Related]
11. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
12. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
Kang JJ; de la Cruz J; Cortina MS
Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
[TBL] [Abstract][Full Text] [Related]
13. Experience with Boston keratoprosthesis type 1 in the developing world.
de Oliveira LA; Pedreira Magalhães F; Hirai FE; de Sousa LB
Can J Ophthalmol; 2014 Aug; 49(4):351-7. PubMed ID: 25103652
[TBL] [Abstract][Full Text] [Related]
14. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
15. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
16. Boston Type I Keratoprosthesis Implantation Following Autologous Submandibular Gland Transplantation for End Stage Ocular Surface Disorders.
Gu J; Zhai J; Liao G; Chen J
Ocul Immunol Inflamm; 2018; 26(3):452-455. PubMed ID: 27726460
[TBL] [Abstract][Full Text] [Related]
17. Complications associated with clear corneal cataract wounds during vitrectomy.
Wong RW; Kokame GT; Mahmoud TH; Mieler WF; Tornambe PE; McDonald HR
Retina; 2010 Jun; 30(6):850-5. PubMed ID: 20090563
[TBL] [Abstract][Full Text] [Related]
18. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
[TBL] [Abstract][Full Text] [Related]
19. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
20. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK.
Liu C; Okera S; Tandon R; Herold J; Hull C; Thorp S
Br J Ophthalmol; 2008 Sep; 92(9):1211-7. PubMed ID: 18511541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
